Back to mobile site

Cellular Dynamics and Roche (RHHBY) Expand Existing Cardiotoxicity Screening Agreement

July 1, 2009 12:59 PM EDT Send to a Friend
Cellular Dynamics International (CDI) and Roche (OTC: RHHBY) announced a significant expansion of their existing agreement to test drug development ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login